How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?

Verbelen, Moira; Lewis, Cathryn M

Verbelen, Moira; Lewis, Cathryn M.

Affiliation

Verbelen M; MRC SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
Lewis CM; MRC SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.

Pharmacogenomics ; 16(9): 915-7, 2015.

Article in En | MEDLINE | ID: mdl-26122865

Subject(s)

Agranulocytosis/chemically induced; Agranulocytosis/genetics; Antipsychotic Agents/adverse effects; Clozapine/adverse effects; Genetic Testing; HLA Antigens/genetics; Humans; Pharmacogenetics

Key words

HLA; agranulocytosis; clozapine; pharmacogenomic testing

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Clozapine / Agranulocytosis Limits: Humans Language: En Journal: Pharmacogenomics Journal subject: FARMACOLOGIA / GENETICA MEDICA Year: 2015 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google